Qiagen N.V.
NYSE:QGENMedical - Diagnostics & Research
-$0.35 today
- Market cap
- $10.23B
- Beta
- 0.66
- P/E (TTM)
- 18.6
- EPS (TTM)
- $1.94
- Dividend yield
- 0.69%
Volume 4.26M
Average 2.07M
QGEN Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Qiagen N.V.NYSE: QGEN
Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares (diluted) declines year over year
Q2 FY2026 weighted avg shares (diluted) of 207.83M shares fell 4.7% year over year, in line with the -4.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 0.5% from the prior quarter. Over 3 fiscal years it compounded at -2.3% a year.
Context
- Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -4.7% toward the trailing-twelve-month pace of -4.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 207.94M USD
- Year-over-year change
- -4.8%
- 4-year CAGR
- -2.0%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 207.94M | -4.8% |
| FY2024 | 2024-12-31 | 218.48M | +0.5% |
| FY2023 | 2023-12-31 | 217.49M | -2.6% |
| FY2022 | 2022-12-31 | 223.23M | -0.8% |
| FY2021 | 2021-12-31 | 225.07M | — |
Weighted Avg Shares (Diluted) vs competitors
How QGEN compares with its peers on the latest reported figures
- QGEN's LTM Jun 2026 weighted avg shares (diluted) of 210.75M shares is the 4th highest of the 11 companies compared; the peer median is 149.17M shares.
- Its year-over-year change of -4.3% is the 10th highest of 11, against a peer median of -0.8%.
- Over three fiscal years its annual growth of -2.3% compares with a peer median of -1.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | 709.15M | -1.9% | -1.2% | |
| LTM Sep 2026 | 373M | -1.7% | -1.5% | |
| LTM Jul 2026 | 283.75M | -1.1% | -1.8% | |
| LTM Jun 2026 | 210.75M | -4.3% | -2.3% | |
| LTM Sep 2026 | 157.22M | -0.4% | -1.0% | |
| LTM Jun 2026 | 152.3M | +0.3% | +0.5% | |
| LTM Jun 2026 | 146.04M | +2.7% | +3.3% | |
| LTM Sep 2026 | 129.04M | +4.4% | +3.1% | |
| LTM Jul 2026 | 113.64M | -5.8% | -3.6% | |
| LTM Jun 2026 | 56.59M | +0.1% | -0.5% | |
| LTM Jun 2026 | 26.93M | -3.1% | -2.9% | |
| Peer median (excluding QGEN) | 149.17M | -0.8% | -1.1% | |
Competitors are the stored peer set for QGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.25B | 2.14B | 1.97B | 1.98B | 2.09B |
| Cost of Revenue | 800.84M | 756.96M | 731.62M | 1.01B | 798.5M |
| Gross Profit | 1.45B | 1.38B | 1.23B | 967.35M | 1.29B |
| Gross Margin | 64.4% | 64.7% | 62.8% | 48.9% | 61.8% |
| Research & Development | 189.96M | 189.86M | 198.51M | 193.49M | 187.52M |
| Selling, General & Admin | 584.47M | 603.95M | 579.17M | 564.36M | 583.67M |
| Operating Expenses | 820.74M | 853.1M | 823.75M | 869.64M | 771.19M |
| Depreciation & Amortization | 214.93M | 208.4M | 205.34M | 203.27M | 193.75M |
| EBITDA | 895.24M | 779.36M | 688.56M | 368.26M | 717.27M |
| EBITDA Margin | 39.8% | 36.4% | 35.0% | 18.6% | 34.3% |
| Operating Income | 630.08M | 531.46M | 409.94M | 97.71M | 520.31M |
| Operating Margin | 28.0% | 24.8% | 20.9% | 4.9% | 24.9% |
| Interest Income | 9.56M | 32.76M | 78.99M | 68.02M | 64.32M |
| Interest Expense | 54.48M | 58.36M | 53.41M | 43.84M | 33.26M |
| Other Income / Expenses | (4.25M) | (18.86M) | 19.87M | 23.44M | (30.04M) |
| Income Before Tax | 625.83M | 512.6M | 429.81M | 121.15M | 490.27M |
| Pre-Tax Margin | 27.8% | 23.9% | 21.9% | 6.1% | 23.5% |
| Income Tax Expense | 113.23M | 89.39M | 88.51M | 37.56M | 65.39M |
| Net Income | 512.6M | 423.21M | 341.3M | 83.59M | 424.88M |
| Net Margin | 22.8% | 19.8% | 17.4% | 4.2% | 20.3% |
| EPS (Basic) | 2.52 | 2.08 | 1.67 | 0.39 | 2.04 |
| EPS (Diluted) | 2.47 | 2.05 | 1.65 | 0.38 | 2.04 |
| Weighted Avg Shares | 221.14M | 220.75M | 217.49M | 216.44M | 207.94M |
| Weighted Avg Shares (Diluted) | 225.07M | 223.23M | 217.49M | 218.48M | 207.94M |
Qiagen N.V.
NYSE:QGEN
Intrinsic Alpha fair value
Locked
Current Price
$49.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.